Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Betsy Davis

Betsy Davis

Senior Strategic Marketing Manager

Connect with Betsy Davis on LinkedIn
Follow Betsy Davis on Twitter
Website:

About the author: Betsy’s entire marketing career has exclusively focused on the STEM market, with a distinct emphasis on Pharma. During her tenure with Elsevier’s Corporate R&D group, she has managed market segmentation for the pharma and life sciences industry, and launched and manages The Hive, a partnership with a select group of biotech and pharmaceutical start-ups focused on early stage innovation in drug discovery and development. The program promotes collaboration and inspiration across the Pharma & Life Sciences industry. Prior to launching her marketing career, Betsy worked as a management consultant focused on strategy implementation. She holds an MBA from the University of Michigan’s Ross School of Business and a BA from Barnard College of Columbia University.

Posts by Betsy Davis

Biosimilars and Pharmacovigilance: What’s Ahead

Posted on May 20th, 2016 in Pharmacovigilance

DNA Magnification

DNA Magnification

In our first blog in this series, we drew from a recent IMS report  to demonstrate the market potential of biosimilars. (more…)

Biosimilars and Pharmacovigilance: What You Need to Know—and Do—Now

Posted on April 26th, 2016 in Pharmacovigilance

A few weeks ago, the US FDA approved Inflectra (infliximab-dyyb), a biosimilar to infliximab. This is the second US biosimilar approval, suggesting others may soon be on the way—good news for companies with biosimilars pending approval and in development. (more…)

Biosimilars and Pharmacovigilance: 5 Key Challenges

Posted on April 7th, 2016 in Pharmacovigilance

The first biosimilar (Zarxio [filgrastim-sndz]) was approved in the US in March 2015, launching what some refer to as a “milestone in the maturity of medical biotechnology.”1 (more…)

POTUS, Data and How to Increase Your Likelihood of Success

Posted on March 10th, 2016 in Pharma R&D

February 25 marked one year since the advent of the President’s Precision Medicine Initiative and the White House marked the anniversary by hosting a PMI Summit, including a panel discussion in which the POTUS himself (more…)

  1. 1
  2. 16
  3. 17
  4. 18
  5. 19